TNYA News and Press, Tenaya Therapeutics Inc. From 03/05/26

2026-03-05 08:54:47 ET More on Alnylam Pharmaceuticals, Tenaya Therapeutics Alnylam Pharmaceuticals, Inc. (ALNY) Presents at TD Cowen 46th Annual Health Care Conference Transcript Alnylam Hit Hard As Investors Forced To Revise Future Profit Expectations Alnylam Pharm...

Agreement Combines Tenaya’s Expertise in Identification and Validation of Genetic Heart Disease Targets with Alnylam’s Ability to Deliver Transformational Therapeutics Tenaya to Receive Up to $10 Million in Upfront Payments in Addition to Research Funding and Milestone Payment...

SOUTH SAN FRANCISCO, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that...

Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with  Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 Trial of Adults with MYBPC3-Associated HCM Expects to Report One-Year Cohort 1 Data and Early Cohort 2 Data from RIDGE™-1 Study ...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 14.6% to $3.29 on volume of 531,992,985 shares Paranovus Entertainment Technology Ltd. (PAVS) rose 19.1% to $0.0411 on volume of 516,994,438 shares Oriental Culture Holding LTD (OC...

A look at the top 10 most actives in the United States Paranovus Entertainment Technology Ltd. (PAVS) rose 16.7% to $0.04025 on volume of 473,890,312 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 14.3% to $3.2805 on volume of 472,166,357 shares cbdMD Inc. (YCBD) rose 72.8% ...

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced the p...

2025-12-11 22:42:49 ET Tenaya Therapeutics, Inc. (TNYA) Discusses Initial Data From RIDGE-1 Phase Ib/II Trial of TN-401 Gene Therapy for ARVC December 11, 2025 5:00 PM EST... Read the full article on Seeking Alpha For further details see: Tenaya Therapeutics, Inc. (TNYA) Dis...

2025-12-11 16:16:06 ET More on Tenaya Therapeutics Tenaya Therapeutics: Risky But Promising Cardiac Gene Platform Tenaya Therapeutics, Inc. (TNYA) Shareholder/Analyst Call - Slideshow Tenaya Therapeutics, Inc. (TNYA) Shareholder/Analyst Call Transcript Tenaya...

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that ...